Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02060968
Other study ID # AMCCV2014-03
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 2014
Est. completion date June 2021

Study information

Verified date September 2021
Source Asan Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate effectiveness and safety of Promus PREMIER in Routine Clinical Practice


Recruitment information / eligibility

Status Completed
Enrollment 2006
Est. completion date June 2021
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Age 20 and more - Intervention with Promus PREMIER everolimus eluting coronary stent - Agreed with written informed consent form Exclusion Criteria: - Intervention with Promus PREMIER everolimus eluting coronary stent and other drug eluting stent at the same time - Life expectancy of 1year and under - Cardiac shock

Study Design


Intervention

Device:
Promus PREMIER


Locations

Country Name City State
Korea, Republic of Hallym University Sacred Heart Hospital Anyang
Korea, Republic of Soon Chun Hyang University Hospital Cheonan Cheonan
Korea, Republic of Chungbuk National University Hospital Cheongju
Korea, Republic of Gangwon National Univ. Hospital Chuncheon
Korea, Republic of Daegu Catholic University Medical Center Daegu
Korea, Republic of Keimyung University Dongsan Medical Center Daegu
Korea, Republic of Yeungnam University Medical Center Daegu
Korea, Republic of Chungnam National University Hospital Daejeon
Korea, Republic of The Catholic University of Korea, Daejeon ST. Mary's Hospital Daejeon
Korea, Republic of Gangneung Asan Hospital Gangneung
Korea, Republic of Gachon University Gil Hospital Incheon
Korea, Republic of Kwangju Christian Hospital Kwangju
Korea, Republic of Inje University Pusan Paik Hospital Pusan
Korea, Republic of Kosin University Hospital Pusan
Korea, Republic of Pusan National University Hospital Pusan
Korea, Republic of Asan Medical Hospital Seoul
Korea, Republic of Eulji General Hospital Seoul
Korea, Republic of Kangdong Sacred Heart Hospital Seoul
Korea, Republic of Korea University Guro Hospital Seoul
Korea, Republic of Kyunghee University Medical Center Seoul
Korea, Republic of The Catholic University of Korea Seoul St. Mary's Hospital Seoul
Korea, Republic of The Catholic University of Korea St. Paul's Hospital Seoul
Korea, Republic of The Catholic University of Korea Uijeongbu St. Mary's Hospital Uijeongbu
Korea, Republic of Ulsan University Hospital Ulsan
Korea, Republic of Pusan National University Yangsan Hospital Yangsan

Sponsors (3)

Lead Sponsor Collaborator
Seung-Jung Park Boston Scientific Korea Co. Ltd, CardioVascular Research Foundation, Korea

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Composite event rate Death, non fatal myocardial infarction, Target Vessel Revascularization 1year
Secondary All death 5year
Secondary Cardiac death 5year
Secondary Myocardial infarction 5year
Secondary Composite event of death or myocardial infarction 5year
Secondary Composite event of cardiac death or myocardial infarction 5year
Secondary Target Vessel revascularization 5year
Secondary Target lesion revascularization 5year
Secondary Stent thrombosis by an Academic Research Consortium (ARC) criteria 5year
Secondary Stroke 5year
Secondary Procedural success defined as less than 30% residual stenosis at the completion of procedure without death or Q wave myocardial infarction or urgent revascularization participants will be followed for the duration of hospital stay, an expected average of 3days. 3day
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A